SERA PROGNOSTICS, INC. Other Labor-related Expenses
SERA PROGNOSTICS, INC. (SERA) reported Other Labor-related Expenses of $5.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherLaborRelatedExpenses · last filed 2026-08-12
- SERA PROGNOSTICS, INC. other labor-related expenses for the quarter ending 2026-06-30 was $5.49M, a 37.45% increase year-over-year.
- SERA PROGNOSTICS, INC. other labor-related expenses for the quarter ending 2026-03-31 was $4.60M, a 17.90% increase year-over-year.
- SERA PROGNOSTICS, INC. other labor-related expenses for the quarter ending 2025-12-31 was $4.49M, a 31.84% increase year-over-year.
- SERA PROGNOSTICS, INC. other labor-related expenses for the quarter ending 2025-09-30 was $4.36M, a 35.15% increase year-over-year.
- SERA PROGNOSTICS, INC. other labor-related expenses for fiscal 2025 was $16.75M, a 26.20% increase from fiscal 2024.
- SERA PROGNOSTICS, INC. other labor-related expenses for fiscal 2024 was $13.27M, a 25.78% decline from fiscal 2023.
- SERA PROGNOSTICS, INC. other labor-related expenses for fiscal 2023 was $17.88M.
| Period end | Other Labor-related Expenses 3 month | Other Labor-related Expenses 6 month | Other Labor-related Expenses 9 month | Other Labor-related Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.49M 10-Q · filed 2026-08-12 | $10.09M 10-Q · filed 2026-08-12 | $14.58M derived: sum of 3 quarters · filed 2026-08-12 | $18.94M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $4.60M 10-Q · filed 2026-05-06 | $9.09M derived: sum of 2 quarters · filed 2026-05-06 | $13.45M derived: sum of 3 quarters · filed 2026-05-06 | $17.44M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $8.85M derived: sum of 2 quarters · filed 2026-03-18 | $12.85M derived: sum of 3 quarters · filed 2026-08-12 | $16.75M 10-K · filed 2026-03-18 |
| 2025-09-30 | $4.36M 10-Q · filed 2025-11-13 | $8.35M derived: sum of 2 quarters · filed 2026-08-12 | $12.25M 10-Q · filed 2025-11-13 | $15.66M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $3.99M 10-Q · filed 2026-08-12 | $7.89M 10-Q · filed 2026-08-12 | $11.30M derived: sum of 3 quarters · filed 2026-08-12 | $14.53M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $3.90M 10-Q · filed 2026-05-06 | $7.31M derived: sum of 2 quarters · filed 2026-05-06 | $10.53M derived: sum of 3 quarters · filed 2026-05-06 | $13.79M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $6.63M derived: sum of 2 quarters · filed 2026-03-18 | $9.89M derived: sum of 3 quarters · filed 2026-03-18 | $13.27M 10-K · filed 2026-03-18 |
| 2024-09-30 | $3.23M 10-Q · filed 2025-11-13 | $6.48M derived: sum of 2 quarters · filed 2025-11-13 | $9.86M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $3.26M 10-Q · filed 2025-08-06 | $6.63M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $3.38M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $17.88M 10-K · filed 2025-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |